Trials / Completed
CompletedNCT00179868
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
- Sex
- All
- Age
- 6 Months – 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | C-Reactive Protein levels | Each patient enrolled in the study will have a serum quantitative c-reactive protein (crp) level drawn on the day of transplant, day 7 of transplant, and twice weekly after that until recovery of neutrophil count (approximately 20-25 days). Patients will be followed for 100 days post-transplant for the development of the following complications: 1. Sepsis- defined as fever, positive blood culture, need for fluid resuscitation and/or pressor support. 2. Acute GVHD \> grade II defined according to the Seattle criteria 3. VOD- defined according to the modified Seattle criteria |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2005-09-16
- Last updated
- 2025-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00179868. Inclusion in this directory is not an endorsement.